Development and implementation of "Check of Medication Appropriateness" (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance.
Charlotte QuintensThomas De RijdtTine Van NieuwenhuyseSteven SimoensWilly E PeetermansBart Van den BoschMinne CasteelsIsabel SprietPublished in: BMC medical informatics and decision making (2019)
These results demonstrate the added value of CMA to support medication surveillance in synergy with already integrated basic clinical decision support and bedside clinical pharmacy. Otherwise, the study also highlighted a number of limitations, allowing improvement of the service.